| 标题 |
Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cardiovascular Diabetology 作者:Lindsay E. Clegg; Robert C. Penland; Srinivas Bachina; David W. Boulton; Marcus Thuresson; et al 出版日期:2019 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)